Long-term oncologic safety remains an open research question because the same migration-promoting and pro-angiogenic activity that supports wound closure has, in some murine melanoma models, correlated with increased metastasis
Submit a Contact Us form below with the required information to start your transformation today
The two methods are intramuscular (IM) and subcutaneous (SC)
2026 Ozempic NAION Lawsuit Updates March 3, 2026 Update: The judge overseeing the federal GLP-1 vision loss litigation selected a group of plaintiffs attorneys to manage discovery and other coordinated pretrial matters involving claims that Ozempic, Wegovy and similar drugs caused permanent vision damage
Approval or Denial: If Approved: Youll receive: Explanation of prescribed dose Injection training materials or video Information about your pharmacy Timeline for delivery Follow-up schedule Contact information for questions If Not Approved: Your provider should explain: Specific reason for denial Alternative options to consider Whether you might qualify in the future Other weight loss approaches Common Reasons for Denial: BMI below threshold without qualifying conditions Contraindications (thyroid cancer history, pregnancy, MEN 2) Dangerous medication interactions Medical conditions making semaglutide unsafe Unrealistic expectations or poor understanding of treatment Most providers want to help but must prioritize safety
Statements from Novo Nordisk emphasize the overall safety profile of semaglutide while acknowledging the need for ongoing monitoring of vision-related side effects
